<p>Phibro Animal Health Corporation（纳斯达克代码：PAHC - 获取免费报告）首席执行官 Jack Bendheim 于 12 月 8 日（星期一）出售了 3,520 股该股票。股票的平均售价为 40.06 美元，总价值为 141,011.20 美元。交易后，首席执行官持有公司 46,240 股股票，估值约为 1,852,374.40 美元。此次交易使其持股减少了 7.07%。该交易已在向 SEC 提交的文件中披露，具体内容可通过此链接查看。</p>
<p>Jack Bendheim 最近还进行了以下交易：</p>
<ul>
<li>在 12 月 9 日（星期二），Jack Bendheim 出售了 1,288 股 Phibro Animal Health 股票。股票的平均售价为 40.19 美元，总交易额为 51,764.72 美元。</li>
<li>在 12 月 3 日（星期三），Jack Bendheim 出售了 3,520 股 Phibro Animal Health 股票。股票的平均售价为 40.77 美元，总交易额为 143,510.40 美元。</li>
<li>在 11 月 25 日（星期二），Jack Bendheim 出售了 7,040 股 Phibro Animal Health 股票。股票的平均售价为 43.93 美元，总交易额为 309,267.20 美元。</li>
<li>在 11 月 26 日（星期三），Jack Bendheim 出售了 5,280 股 Phibro Animal Health 股票。股票的平均售价为 44.02 美元，总交易额为 232,425.60 美元。</li>
<li>在 11 月 17 日（星期一），Jack Bendheim 出售了 5,280 股 Phibro Animal Health 股票。股票的平均售价为 44.56 美元，总价值为 235,276.80 美元。</li>
<li>在 11 月 13 日（星期四），Jack Bendheim 出售了 8,801 股 Phibro Animal Health 股票。股票的平均售价为 44.47 美元，总价值为 391,380.47 美元。</li>
<li>在 11 月 12 日（星期三），Jack Bendheim 出售了 21,536 股 Phibro Animal Health 股票。股票的平均售价为 45.23 美元，总价值为 974,073.28 美元。</li>
<li>在 11 月 10 日（星期一），Jack Bendheim 出售了 38,303 股 Phibro Animal Health 股票。股票的平均售价为 45.29 美元，总价值为 1,734,742.87 美元。</li>
<li>在 11 月 7 日（星期五），Jack Bendheim 出售了 3,520 股 Phibro Animal Health 股票。股票的平均售价为 42.86 美元，总价值为 150,867.20 美元。</li>
<li>在 11 月 4 日（星期二），Jack Bendheim 出售了 3,520 股 Phibro Animal Health 股票。股票的平均售价为 43.10 美元，总价值为 151,712.00 美元。</li>
</ul>
<p>获取 <strong>Phibro Animal Health</strong> 的提醒：</p>
<h2>Phibro Animal Health 股票上涨 4.3%</h2>
<p>在周三的午盘交易中，纳斯达克代码：PAHC 的股票上涨了 1.63 美元，达到了 39.91 美元。该股票的交易量为 282,957 股，而其平均交易量为 280,482 股。该公司的市值为 16.2 亿美元，市盈率为 24.04，PEG 比率为 1.14，贝塔值为 0.77。Phibro Animal Health Corporation 的 12 个月低点为 16.16 美元，12 个月高点为 46.42 美元。该公司的 50 日简单移动平均线为 41.18 美元，200 日简单移动平均线为 34.31 美元。该公司的速动比率为 1.35，流动比率为 3.09，债务与股本比率为 2.32。</p>
<p>Phibro Animal Health（纳斯达克代码：PAHC - 获取免费报告）最近于 11 月 5 日（星期三）公布了季度财报。该公司报告本季度每股收益为 0.73 美元，超出分析师一致预期的 0.58 美元，超出幅度为 0.15 美元。该公司在本季度的收入为 3.6389 亿美元，而分析师预期为 3.4544 亿美元。Phibro Animal Health 的净利润率为 4.85%，股本回报率为 36.26%。Phibro Animal Health 已将其 2026 财年的指引设定为每股收益 2.640-2.810 美元。平均而言，卖方分析师预测 Phibro Animal Health Corporation 本财年的每股收益为 1.95 美元。</p>
<h2>Phibro Animal Health 宣布分红</h2>
<p>该公司还最近宣布了一项季度分红，将于 12 月 17 日（星期三）支付。11 月 26 日（星期三）登记在册的股东将获得每股 0.12 美元的分红。这相当于每年 0.48 美元的分红和 1.2% 的分红收益率。除息日期为 11 月 26 日（星期三）。Phibro Animal Health 目前的派息比率为 28.92%。</p>
<h2>分析师评级上调和下调</h2>
<p>一些研究分析师最近对该公司进行了评估。摩根大通将 Phibro Animal Health 的目标价从 45.00 美元上调至 50.00 美元，并在 11 月 7 日（星期五）的报告中给予该股票 “超配” 评级。美国银行将 Phibro Animal Health 的目标价从 19.00 美元上调至 27.00 美元，并在 8 月 29 日（星期五）的报告中给予该公司 “表现不佳” 评级。Weiss Ratings 在周一的研究报告中重申了对 Phibro Animal Health 的 “买入（b-）” 评级。Zacks Research 在 11 月 10 日（星期一）的报告中将 Phibro Animal Health 的评级从 “强力买入” 下调至 “持有”。最后，摩根士丹利在 8 月 28 日（星期四）的报告中将 Phibro Animal Health 的目标价设定为 34.00 美元。两位投资分析师对该股票给予了买入评级，四位给予了持有评级，两位给予了卖出评级。根据 MarketBeat 的数据，Phibro Animal Health 目前的共识评级为 “持有”，平均目标价为 31.40 美元。</p>
<p><strong>获取我们最新的 PAHC 股票分析</strong></p>
<h2>机构资金流入和流出</h2>
<p>最近，一些对冲基金和其他机构投资者买卖了 PAHC 的股票。Cetera Investment Advisers 在第一季度将其在 Phibro Animal Health 的持股增加了 18.9%。Cetera Investment Advisers 现在拥有 11,550 股该公司的股票，价值 247,000 美元，此前在上个季度又购买了 1,840 股。LPL Financial LLC 在第一季度将其在 Phibro Animal Health 的持股增加了 46.8%。LPL Financial LLC 现在拥有 128,335 股该公司的股票，价值 2,741,000 美元，此前在上个季度又收购了 40,889 股。Vanguard Group Inc.在第一季度将其在 Phibro Animal Health 的持股增加了 0.4%。Vanguard Group Inc.现在拥有 1,521,520 股该公司的股票，估值为 32,500,000 美元，此前在上个季度又收购了 6,784 股。加拿大国家银行 FI 在第一季度新建了在 Phibro Animal Health 的持仓，估值约为 30,000 美元。最后，Invesco Ltd.在第一季度将其在 Phibro Animal Health 的持股增加了 92.3%。Invesco Ltd.现在拥有 387,739 股该公司的股票，价值 8,282,000 美元，此前在上个季度又购买了 186,087 股。机构投资者和对冲基金持有该公司 99.34% 的股票。</p>
<h2>Phibro Animal Health 公司简介</h2>
<p>(获取免费报告)</p>
<p>Phibro Animal Health Corporation 是一家在美国、以色列、巴西、爱尔兰及国际上运营的动物健康和矿物营养公司。它通过三个部门运营：动物健康、矿物营养和性能产品。该公司开发、制造和销售各种食品和伴侣动物的产品，包括家禽、猪、牛和奶牛、水产养殖和狗。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过 Phibro Animal Health</li>
<li>2025 年有潜力上涨的两只 CRM 平台股票</li>
<li>2026 年将主导市场的三大投资主题</li>
<li>什么样的股票是好的分红股票？</li>
<li>Vertical 的 Valo 发布：伪装成下跌的商业飞跃</li>
<li>加拿大便士股票：它们能让你致富吗？</li>
<li>2026 年的分红股票：市场降温时的投资方向</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEFIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEFIQw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Phibro Animal Health 吗？</h2>
<p>在考虑 Phibro Animal Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，而 Phibro Animal Health 并不在名单上。</p>
<p>虽然 Phibro Animal Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

PAHC

<p>Phibro Animal Health 首席执行官 Jack Bendheim 出售了 3,520 股，减少了 7.07% 的持股比例。这些股票以每股 40.06 美元的价格出售，总计 141,011.20 美元。出售后，Bendheim 拥有 46,240 股，价值 1,852,374.40 美元。此交易已在 SEC 文件中披露。此外，Bendheim 最近还进行了几笔其他股票出售。Phibro 的股票上涨了 4.3%，达到 39.91 美元，市值为 16.2 亿美元。公司宣布每股季度分红 0.12 美元，派息比率为 28.92%。分析师已调整了对公司的目标价格</p>

<p>Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) CEO Jack Bendheim sold 3,520 shares of the stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $40.06, for a total value of $141,011.20. Following the transaction, the chief executive officer owned 46,240 shares of the company's stock, valued at approximately $1,852,374.40. The trade was a 7.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.</p>
<div class="lb-trans"><p>Phibro Animal Health Corporation（纳斯达克代码：PAHC - 获取免费报告）首席执行官 Jack Bendheim 于 12 月 8 日（星期一）出售了 3,520 股该股票。股票的平均售价为 40.06 美元，总价值为 141,011.20 美元。交易后，首席执行官持有公司 46,240 股股票，估值约为 1,852,374.40 美元。此次交易使其持股减少了 7.07%。该交易已在向 SEC 提交的文件中披露，具体内容可通过此链接查看。</p>
</div><p>Jack Bendheim also recently made the following trade(s):</p>
<div class="lb-trans"><p>Jack Bendheim 最近还进行了以下交易：</p>
</div><ul>
<li>On Tuesday, December 9th, Jack Bendheim sold 1,288 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.19, for a total transaction of $51,764.72.</li>
<li>On Wednesday, December 3rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.77, for a total transaction of $143,510.40.</li>
<li>On Tuesday, November 25th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The shares were sold at an average price of $43.93, for a total transaction of $309,267.20.</li>
<li>On Wednesday, November 26th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.02, for a total transaction of $232,425.60.</li>
<li>On Monday, November 17th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The shares were sold at an average price of $44.56, for a total value of $235,276.80.</li>
<li>On Thursday, November 13th, Jack Bendheim sold 8,801 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.47, for a total value of $391,380.47.</li>
<li>On Wednesday, November 12th, Jack Bendheim sold 21,536 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.23, for a total value of $974,073.28.</li>
<li>On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.29, for a total value of $1,734,742.87.</li>
<li>On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $42.86, for a total value of $150,867.20.</li>
<li>On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $43.10, for a total value of $151,712.00.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 12 月 9 日（星期二），Jack Bendheim 出售了 1,288 股 Phibro Animal Health 股票。股票的平均售价为 40.19 美元，总交易额为 51,764.72 美元。</li>
<li>在 12 月 3 日（星期三），Jack Bendheim 出售了 3,520 股 Phibro Animal Health 股票。股票的平均售价为 40.77 美元，总交易额为 143,510.40 美元。</li>
<li>在 11 月 25 日（星期二），Jack Bendheim 出售了 7,040 股 Phibro Animal Health 股票。股票的平均售价为 43.93 美元，总交易额为 309,267.20 美元。</li>
<li>在 11 月 26 日（星期三），Jack Bendheim 出售了 5,280 股 Phibro Animal Health 股票。股票的平均售价为 44.02 美元，总交易额为 232,425.60 美元。</li>
<li>在 11 月 17 日（星期一），Jack Bendheim 出售了 5,280 股 Phibro Animal Health 股票。股票的平均售价为 44.56 美元，总价值为 235,276.80 美元。</li>
<li>在 11 月 13 日（星期四），Jack Bendheim 出售了 8,801 股 Phibro Animal Health 股票。股票的平均售价为 44.47 美元，总价值为 391,380.47 美元。</li>
<li>在 11 月 12 日（星期三），Jack Bendheim 出售了 21,536 股 Phibro Animal Health 股票。股票的平均售价为 45.23 美元，总价值为 974,073.28 美元。</li>
<li>在 11 月 10 日（星期一），Jack Bendheim 出售了 38,303 股 Phibro Animal Health 股票。股票的平均售价为 45.29 美元，总价值为 1,734,742.87 美元。</li>
<li>在 11 月 7 日（星期五），Jack Bendheim 出售了 3,520 股 Phibro Animal Health 股票。股票的平均售价为 42.86 美元，总价值为 150,867.20 美元。</li>
<li>在 11 月 4 日（星期二），Jack Bendheim 出售了 3,520 股 Phibro Animal Health 股票。股票的平均售价为 43.10 美元，总价值为 151,712.00 美元。</li>
</ul>
</div><p>Get <strong>Phibro Animal Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Phibro Animal Health</strong> 的提醒：</p>
</div><h2>Phibro Animal Health Stock Up 4.3%</h2>
<div class="lb-trans"><h2>Phibro Animal Health 股票上涨 4.3%</h2>
</div><p>Shares of NASDAQ:PAHC traded up $1.63 during midday trading on Wednesday, hitting $39.91. The stock had a trading volume of 282,957 shares, compared to its average volume of 280,482. The company has a market cap of $1.62 billion, a P/E ratio of 24.04, a PEG ratio of 1.14 and a beta of 0.77. Phibro Animal Health Corporation has a 12 month low of $16.16 and a 12 month high of $46.42. The business's 50-day simple moving average is $41.18 and its 200-day simple moving average is $34.31. The company has a quick ratio of 1.35, a current ratio of 3.09 and a debt-to-equity ratio of 2.32.</p>
<div class="lb-trans"><p>在周三的午盘交易中，纳斯达克代码：PAHC 的股票上涨了 1.63 美元，达到了 39.91 美元。该股票的交易量为 282,957 股，而其平均交易量为 280,482 股。该公司的市值为 16.2 亿美元，市盈率为 24.04，PEG 比率为 1.14，贝塔值为 0.77。Phibro Animal Health Corporation 的 12 个月低点为 16.16 美元，12 个月高点为 46.42 美元。该公司的 50 日简单移动平均线为 41.18 美元，200 日简单移动平均线为 34.31 美元。该公司的速动比率为 1.35，流动比率为 3.09，债务与股本比率为 2.32。</p>
</div><p>Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 EPS for the quarter, beating analysts' consensus estimates of $0.58 by $0.15. The firm had revenue of $363.89 million during the quarter, compared to analysts' expectations of $345.44 million. Phibro Animal Health had a net margin of 4.85% and a return on equity of 36.26%. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, sell-side analysts forecast that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Phibro Animal Health（纳斯达克代码：PAHC - 获取免费报告）最近于 11 月 5 日（星期三）公布了季度财报。该公司报告本季度每股收益为 0.73 美元，超出分析师一致预期的 0.58 美元，超出幅度为 0.15 美元。该公司在本季度的收入为 3.6389 亿美元，而分析师预期为 3.4544 亿美元。Phibro Animal Health 的净利润率为 4.85%，股本回报率为 36.26%。Phibro Animal Health 已将其 2026 财年的指引设定为每股收益 2.640-2.810 美元。平均而言，卖方分析师预测 Phibro Animal Health Corporation 本财年的每股收益为 1.95 美元。</p>
</div><h2>Phibro Animal Health Announces Dividend</h2>
<div class="lb-trans"><h2>Phibro Animal Health 宣布分红</h2>
</div><p>The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 17th. Stockholders of record on Wednesday, November 26th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Wednesday, November 26th. Phibro Animal Health's payout ratio is currently 28.92%.</p>
<div class="lb-trans"><p>该公司还最近宣布了一项季度分红，将于 12 月 17 日（星期三）支付。11 月 26 日（星期三）登记在册的股东将获得每股 0.12 美元的分红。这相当于每年 0.48 美元的分红和 1.2% 的分红收益率。除息日期为 11 月 26 日（星期三）。Phibro Animal Health 目前的派息比率为 28.92%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调和下调</h2>
</div><p>A number of research analysts recently weighed in on the company. JPMorgan Chase &amp; Co. boosted their target price on Phibro Animal Health from $45.00 to $50.00 and gave the stock an &#34;overweight&#34; rating in a report on Friday, November 7th. Bank of America upped their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an &#34;underperform&#34; rating in a report on Friday, August 29th. Weiss Ratings restated a &#34;buy (b-)&#34; rating on shares of Phibro Animal Health in a research note on Monday. Zacks Research cut shares of Phibro Animal Health from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Monday, November 10th. Finally, Morgan Stanley set a $34.00 price objective on Phibro Animal Health in a report on Thursday, August 28th. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Phibro Animal Health currently has a consensus rating of &#34;Hold&#34; and an average target price of $31.40.</p>
<div class="lb-trans"><p>一些研究分析师最近对该公司进行了评估。摩根大通将 Phibro Animal Health 的目标价从 45.00 美元上调至 50.00 美元，并在 11 月 7 日（星期五）的报告中给予该股票 “超配” 评级。美国银行将 Phibro Animal Health 的目标价从 19.00 美元上调至 27.00 美元，并在 8 月 29 日（星期五）的报告中给予该公司 “表现不佳” 评级。Weiss Ratings 在周一的研究报告中重申了对 Phibro Animal Health 的 “买入（b-）” 评级。Zacks Research 在 11 月 10 日（星期一）的报告中将 Phibro Animal Health 的评级从 “强力买入” 下调至 “持有”。最后，摩根士丹利在 8 月 28 日（星期四）的报告中将 Phibro Animal Health 的目标价设定为 34.00 美元。两位投资分析师对该股票给予了买入评级，四位给予了持有评级，两位给予了卖出评级。根据 MarketBeat 的数据，Phibro Animal Health 目前的共识评级为 “持有”，平均目标价为 31.40 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on PAHC</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 PAHC 股票分析</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds and other institutional investors have recently bought and sold shares of PAHC. Cetera Investment Advisers grew its stake in Phibro Animal Health by 18.9% during the first quarter. Cetera Investment Advisers now owns 11,550 shares of the company's stock worth $247,000 after buying an additional 1,840 shares in the last quarter. LPL Financial LLC boosted its position in shares of Phibro Animal Health by 46.8% during the 1st quarter. LPL Financial LLC now owns 128,335 shares of the company's stock worth $2,741,000 after acquiring an additional 40,889 shares in the last quarter. Vanguard Group Inc. increased its stake in Phibro Animal Health by 0.4% in the first quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company's stock valued at $32,500,000 after acquiring an additional 6,784 shares during the last quarter. National Bank of Canada FI acquired a new position in Phibro Animal Health during the first quarter valued at approximately $30,000. Finally, Invesco Ltd. lifted its stake in Phibro Animal Health by 92.3% during the first quarter. Invesco Ltd. now owns 387,739 shares of the company's stock worth $8,282,000 after purchasing an additional 186,087 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company's stock.</p>
<div class="lb-trans"><p>最近，一些对冲基金和其他机构投资者买卖了 PAHC 的股票。Cetera Investment Advisers 在第一季度将其在 Phibro Animal Health 的持股增加了 18.9%。Cetera Investment Advisers 现在拥有 11,550 股该公司的股票，价值 247,000 美元，此前在上个季度又购买了 1,840 股。LPL Financial LLC 在第一季度将其在 Phibro Animal Health 的持股增加了 46.8%。LPL Financial LLC 现在拥有 128,335 股该公司的股票，价值 2,741,000 美元，此前在上个季度又收购了 40,889 股。Vanguard Group Inc.在第一季度将其在 Phibro Animal Health 的持股增加了 0.4%。Vanguard Group Inc.现在拥有 1,521,520 股该公司的股票，估值为 32,500,000 美元，此前在上个季度又收购了 6,784 股。加拿大国家银行 FI 在第一季度新建了在 Phibro Animal Health 的持仓，估值约为 30,000 美元。最后，Invesco Ltd.在第一季度将其在 Phibro Animal Health 的持股增加了 92.3%。Invesco Ltd.现在拥有 387,739 股该公司的股票，价值 8,282,000 美元，此前在上个季度又购买了 186,087 股。机构投资者和对冲基金持有该公司 99.34% 的股票。</p>
</div><h2>Phibro Animal Health Company Profile</h2>
<div class="lb-trans"><h2>Phibro Animal Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.</p>
<div class="lb-trans"><p>Phibro Animal Health Corporation 是一家在美国、以色列、巴西、爱尔兰及国际上运营的动物健康和矿物营养公司。它通过三个部门运营：动物健康、矿物营养和性能产品。该公司开发、制造和销售各种食品和伴侣动物的产品，包括家禽、猪、牛和奶牛、水产养殖和狗。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Phibro Animal Health</li>
<li>2 Rising CRM Platform Stocks That Can Surge Higher in 2025</li>
<li>The Top 3 Investment Themes That Will Dominate 2026</li>
<li>What Makes a Stock a Good Dividend Stock?</li>
<li>Vertical’s Valo Launch: A Commercial Leap Disguised as a Dip</li>
<li>Canadian Penny Stocks: Can They Make You Rich?</li>
<li>Dividend Stocks for 2026: Where to Invest as the Market Cools</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Phibro Animal Health</li>
<li>2025 年有潜力上涨的两只 CRM 平台股票</li>
<li>2026 年将主导市场的三大投资主题</li>
<li>什么样的股票是好的分红股票？</li>
<li>Vertical 的 Valo 发布：伪装成下跌的商业飞跃</li>
<li>加拿大便士股票：它们能让你致富吗？</li>
<li>2026 年的分红股票：市场降温时的投资方向</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEFIQw" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NASDAQ&amp;Symbol=PAHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Phibro Animal Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Phibro Animal Health 吗？</h2>
</div><p>Before you consider Phibro Animal Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Phibro Animal Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，而 Phibro Animal Health 并不在名单上。</p>
</div><p>While Phibro Animal Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Phibro Animal Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Phibro Animal Health（纳斯达克代码：PAHC）的首席执行官 Jack Bendheim 出售了 3,520 股股票